TWD
PRME icon

True Wealth Design’s Prime Medicine PRME Stock Holding History

True Wealth Design’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-152
Closed -$529 – 2842
2026
Q1 		$529 Buy
152
+37
+32% +$141 ﹤0.01% 2028
2025
Q4 		$400 Hold
115
– – ﹤0.01% 2024
2025
Q3 		$638 Hold
115
– – ﹤0.01% 1928
2025
Q2 		$285 Buy
115
+65
+130% +$100 ﹤0.01% 1959
2025
Q1 		$100 Buy
+50
New +$128 ﹤0.01% 2198

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

True Wealth Design's PRME Position: Q2 2026 in Review

True Wealth Design sold out of Prime Medicine (PRME) in Q2 2026, closing a stake of 152 shares — an estimated $529 sold.

True Wealth Design first reported a position in PRME in Q1 2025 and held it in 5 quarters. The position peaked at $638 in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • True Wealth Design reported no remaining Prime Medicine position as of Q2 2026 after selling out during the quarter.
  • True Wealth Design sold 152 Prime Medicine shares in Q2 2026, an estimated $529.
  • True Wealth Design first reported a position in Prime Medicine in Q1 2025 and held it in 5 quarters.
  • True Wealth Design's Prime Medicine position peaked at $638 in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on True Wealth Design's 13F filing for Q2 2026, filed 16 Jul 2026.